home
About Us
People
Portfolio
Contact Us
INVESTOR LOGIN
Fund II Investor Login »
Fund III Investor Login »
Fund IV Investor Login »
Fund V Investor Log In »
home
About Us
People
Portfolio
Contact Us
Fund II Investor Login »
Fund III Investor Login »
Fund IV Investor Login »
Fund V Investor Log In »
Dynavax
« Back to company
$175 million
Biopharma
Infectious Diseases and Oncology